abstract |
The present invention relates to compounds of formula (1) and (2) for the treatment of cancer, inflammation, autoimmune diseases, diabetes and diabetic complications, infections, cardiovascular diseases and ischemic reperfusion injury, and pharmaceuticals thereof Relating to acceptable salts. |